Maha Kosa

1.3k total citations
9 papers, 837 citations indexed

About

Maha Kosa is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maha Kosa has authored 9 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maha Kosa's work include HIV/AIDS drug development and treatment (4 papers), Chemical Synthesis and Analysis (3 papers) and Advanced Breast Cancer Therapies (3 papers). Maha Kosa is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Chemical Synthesis and Analysis (3 papers) and Advanced Breast Cancer Therapies (3 papers). Maha Kosa collaborates with scholars based in United States. Maha Kosa's co-authors include Bhasker V. Shetty, Amy K. Patick, Jay F. Davies, Krzysztof Appelt, Siegfried Reich, Jeffrey A. Burgess, Kenneth S.E. Su, Vincent J. Kalish, Bruce A. Dressman and Kristina Campanale and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Maha Kosa

8 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha Kosa United States 6 315 284 282 170 112 9 837
Mark W. Stahlhut United States 21 264 0.8× 600 2.1× 656 2.3× 252 1.5× 112 1.0× 45 1.7k
Hon C. Hui United States 20 367 1.2× 580 2.0× 572 2.0× 109 0.6× 83 0.7× 25 1.3k
Bruno Simoneau Canada 18 485 1.5× 338 1.2× 348 1.2× 241 1.4× 61 0.5× 35 1.2k
Lianhong Xu United States 18 378 1.2× 270 1.0× 231 0.8× 146 0.9× 92 0.8× 42 920
Melissa S. Egbertson United States 20 535 1.7× 771 2.7× 664 2.4× 564 3.3× 97 0.9× 35 1.8k
Vincent Lévêque United States 28 219 0.7× 549 1.9× 659 2.3× 128 0.8× 180 1.6× 41 1.7k
Tim H. M. Jonckers Belgium 17 412 1.3× 383 1.3× 334 1.2× 197 1.2× 25 0.2× 32 981
Rajeshri G. Karki United States 17 299 0.9× 420 1.5× 283 1.0× 226 1.3× 62 0.6× 25 778
Ginette McKercher Canada 14 164 0.5× 196 0.7× 502 1.8× 244 1.4× 24 0.2× 30 982
Robert Zahler United States 25 834 2.6× 680 2.4× 352 1.2× 130 0.8× 202 1.8× 49 1.8k

Countries citing papers authored by Maha Kosa

Since Specialization
Citations

This map shows the geographic impact of Maha Kosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Kosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Kosa more than expected).

Fields of papers citing papers by Maha Kosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Kosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Kosa. The network helps show where Maha Kosa may publish in the future.

Co-authorship network of co-authors of Maha Kosa

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Kosa. A scholar is included among the top collaborators of Maha Kosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Kosa. Maha Kosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sun, Wan, Karen J. Klamerus, Sylvester Pawlak, et al.. (2017). Impact of Acid‐Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH‐Dependent Solubility, With Different Food Intake Conditions. Clinical Pharmacology in Drug Development. 6(6). 614–626. 58 indexed citations
2.
Hoffman, Justin, Cho‐Ming Loi, Melissa O’Gorman, et al.. (2016). Abstract LB-196: A phase I open-label, fixed-sequence, two-period crossover study of the effect of multiple doses of Itraconazole on Palbociclib (PD–0332991) pharmacokinetics in healthy volunteers. Cancer Research. 76(14_Supplement). LB–196. 2 indexed citations
3.
Hoffman, Justin, Anna Plotka, Melissa O’Gorman, et al.. (2015). Abstract 4515: A phase 1 randomized, open-label, fixed-sequence, 2-period study of the effect of multiple doses of rifampin on palbociclib (PD-0332991) pharmacokinetics in healthy volunteers. Cancer Research. 75(15_Supplement). 4515–4515. 3 indexed citations
4.
Dragovich, Peter S., Thomas J. Prins, Ru Zhou, et al.. (1999). Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P1 Lactam Moieties as l-Glutamine Replacements. Journal of Medicinal Chemistry. 42(7). 1213–1224. 139 indexed citations
5.
Kaldor, Stephen W., Vincent J. Kalish, Jay F. Davies, et al.. (1997). Viracept (Nelfinavir Mesylate, AG1343):  A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease. Journal of Medicinal Chemistry. 40(24). 3979–3985. 483 indexed citations
6.
Webber, S. E., Charlotte A. Bartlett, Theodore J. Boritzki, et al.. (1996). AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies. Cancer Chemotherapy and Pharmacology. 37(6). 509–517. 75 indexed citations
7.
Shetty, Bhasker V., et al.. (1996). Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease. Antimicrobial Agents and Chemotherapy. 40(1). 110–114. 50 indexed citations
8.
Melnick, Michael, Siegfried Reich, Anthony J. Trippe, et al.. (1996). Bis Tertiary Amide Inhibitors of the HIV-1 Protease Generated via Protein Structure-Based Iterative Design. Journal of Medicinal Chemistry. 39(14). 2795–2811. 27 indexed citations
9.
Melnick, Michael, Siegfried Reich, Anthony J. Trippe, et al.. (1996). ChemInform Abstract: Bis Tertiary Amide Inhibitors of the HIV‐1 Protease Generated via Protein Structure‐Based Iterative Design.. ChemInform. 27(43).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark W. Stahlhut Breakdown of academic impact, for papers by Hon C. Hui Breakdown of academic impact, for papers by Bruno Simoneau Breakdown of academic impact, for papers by Lianhong Xu Breakdown of academic impact, for papers by Melissa S. Egbertson Breakdown of academic impact, for papers by Vincent Lévêque Breakdown of academic impact, for papers by Tim H. M. Jonckers Breakdown of academic impact, for papers by Rajeshri G. Karki Breakdown of academic impact, for papers by Ginette McKercher Breakdown of academic impact, for papers by Robert Zahler
Rankless by CCL
2026